Earnings: Allergan sheds poor lap-band sales, stays pretty in Q2

Wed, 08/01/2012 - 3:44pm
Mass Device

Shares of Irvine, Calif-based aesthetic medical device and pharmaceutical company Allergan rise on Wall Street after the company reports strong profits in the 2nd quarter.

Allergan logo

Allergan (NYSE:AGN) is sitting pretty, following stronger than expected results for the 2nd quarter, despite a precipitous drop-off in the company's Lap-Band obesity treatment business.

The Irvine, Calif-based medical aesthetic medical device and pharmaceutical company reported net earnings of $295.4 million on $1.49 billion in sales, a 19% increase from the $246.6 million on $1.42 billion in sales the company reported for the same period last year.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.